9
Participants
Start Date
May 31, 2013
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2015
Allopurinol
This is a clinical trial comparing the effect of 80 mg/day of febuxostat to 400 mg/day of allopurinol on the urinary excretion of 2,8-dihydroxyadenine in patients with APRT deficiency.
Febuxostat
This is a clinical trial comparing the effect of 80 mg/day of febuxostat to 400 mg/day of allopurinol on the urinary excretion of 2,8-dihydroxyadenine in patients with APRT deficiency.
Landspitali - The National University Hospital of Iceland, Reykjavik
Collaborators (1)
Mayo Clinic
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Landspitali University Hospital
OTHER